Invictus RG’s Medpace MEDP Stock Holding History

Invictus RG’s Portfolio MEDP Stock Details MEDP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-1,865	Closed	-$59K	–	394
2017 Q3	$59K	Buy	+1,865	New	+$57K	0.05%	346
2017 Q1	–	Sell	-9,297	Closed	-$335K	–	784
2016 Q4	$335K	Buy	+9,297	New	+$310K	0.22%	174

Other funds holding MEDP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BCA

Bernzott Capital Advisors Camarillo, California $209M AUM 9.57% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

GIP

Granite Investment Partners El Segundo, California $1.63B AUM 38.09% 1-Year Est. Return

CCMLC

Cardinal Capital Management LLC (Connecticut) Greenwich, Connecticut $365M AUM 18.32% 1-Year Est. Return

Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return

MWNA

Marshall Wace North America New York $23.5B AUM 46.46% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Invictus RG's MEDP Position: Q4 2017 in Review

Invictus RG sold out of Medpace (MEDP) in Q4 2017, closing a stake of 1,865 shares — an estimated $59K sold.

Invictus RG first reported a position in MEDP in Q4 2016 and held it in 2 quarters. The position peaked at $335K in Q4 2016. 113 funds tracked by Wall St. Rank hold MEDP as of Q4 2017.

Invictus RG reported no remaining Medpace position as of Q4 2017 after selling out during the quarter.
Invictus RG sold 1,865 Medpace shares in Q4 2017, an estimated $59K.
Invictus RG first reported a position in Medpace in Q4 2016 and held it in 2 quarters.
Invictus RG's Medpace position peaked at $335K in Q4 2016.
113 funds tracked by Wall St. Rank held Medpace as of Q4 2017.

Based on Invictus RG's 13F filing for Q4 2017, filed 13 Feb 2018.